Kraj: Włochy
Język: angielski
Źródło: HMA (Heads of Medicines Agencies)
enrofloxacin 15 mg
Le Vet B.V
QJ01MA90
Tablet
enrofloxacin
Cats, Dogs
2011-01-08
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Floxabactin 15 mg tablets for cats and dogs Floxabactin Vet. (DK) Floxabactin Vet. 15 mg tablets for cats and dogs (SE, NO, FI) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: ACTIVE SUBSTANCE: Enrofloxacin 15.0 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Tablet A slightly yellow, round, convex snap-tab tablet for oral administration to dogs and cats. The tablet can be divided into equal halves. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs and cats 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES In cats: treatment of upper respiratory tract infections In dogs: - treatment of lower urinary tract infections (associated or not with prostatitis) and upper urinary tract infections caused by Escherichia coli or Proteus mirabilis. - Treatment of superficial and deep pyoderma. 4.3 CONTRAINDICATIONS Do not use in young or growing dogs (dogs aged less than 12 months (small breed) or less than 18 months (large breed)) as the product may cause epiphyseal cartilage alterations in growing puppies. Do not use in young, growing cats, because of the possibility of the development of cartilage lesions. (cats aged less than 3 months or weighing less than 1kg). Do not use in cats or dogs having seizure disorders, since enrofloxacin may cause CNS stimulation. Do not use in cats or dogs with kno Przeczytaj cały dokument